First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late
Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue DamageEuropean Medical Journal Innovations2021
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic ImpairmentDrugs in R and D2021
Experimental Pharmacotherapy for COVID-19: The Latest AdvancesJournal of Experimental Pharmacology2021
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 PneumoniaFrontiers in Immunology2021
SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19PLoS Computational Biology2021
Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements3 Biotech2021
Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based ReviewJournal of Inflammation Research2021
Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumoniaJournal of Medical Virology2021
Compassionate use of tocilizumab in severe SARS-CoV2 pneumoniaInternational Journal of Infectious Diseases2021
Repurposed Tocilizumab in Patients with Severe COVID-19Journal of Immunology2021
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaClinical Pharmacology and Therapeutics2021
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statementAnnals of the Rheumatic Diseases2021
Current pharmacological treatments for COVID-19: What's next?British Journal of Pharmacology2020
Translating IL-6 biology into effective treatmentsNature Reviews Rheumatology2020
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemicNature Reviews Rheumatology2020
A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress SyndromeJournal of Clinical Pharmacology2020
Consider Adjunctive Ketamine in Mechanically Ventilated Coronavirus Disease-2019 PatientsJournal of Cardiothoracic and Vascular Anesthesia2020
IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?Pharmaceutical Medicine2020
Applied Clinical Pharmacology in a Crisis: Interleukin-6 Axis Blockade and COVID-19Clinical Pharmacology and Therapeutics2020
Pharmacological treatments of COVID-19Pharmacological Reports2020
Knowledge, Attitudes, and Practice Regarding COVID-19 among Patients with Musculoskeletal and Rheumatic Diseases in Nepal: A Web-Based Cross-Sectional StudyOpen Access Rheumatology: Research and Reviews2020
Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literatureDrugs and Therapy Perspectives2020
Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and TocilizumabIndian Pediatrics2020
Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand FrameworkStatistics in Biopharmaceutical Research2020
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?BMC Medicine2020
Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19Frontiers in Public Health2020
Outlook of IL-6 signaling blockade for COVID-19 pneumoniaInflammation and Regeneration2020